All sites C00-96,D32-33,D42-43,D45-47,D76 284 268 257 249 270 263 283 252 244 238 232 246 233 260 244 240 250 255 245 239 272 263
Mouth, pharynx C00-14 4.3 4.5 4.6 3.6 4.2 2.8 4.7 2.7 1.8 6.0 2.2 5.4 3.3 4.4 3.1 1.0 3.2 3.5 3.8 4.0 3.7 3.9
  Lip C00 0.3 0.5 0.5 0.3 0.3 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.3 0.7 0.5 0.7 0.4 0.3 - 0.3 - 0.3
  Tongue C02 1.1 1.4 0.9 1.0 1.1 0.2 1.0 0.8 0.3 1.5 0.7 1.2 0.7 1.5 0.5 0.1 0.5 1.9 1.0 0.6 0.7 1.0
  Mouth, other C03-06 1.1 1.2 1.4 0.5 0.9 0.9 1.4 0.7 0.6 3.1 0.6 1.7 1.2 0.4 0.8 0.2 1.3 1.1 1.2 1.5 1.8 1.1
  Salivary glands C07-08 0.6 0.6 0.6 0.9 0.7 0.6 0.3 0.6 0.6 0.4 0.5 1.0 0.8 0.5 0.3 - 0.6 0.1 0.1 0.4 0.2 0.6
  Pharynx C01,C09-14 1.2 0.8 1.4 0.9 1.1 1.0 1.6 0.5 0.2 0.8 0.3 1.0 0.3 1.2 1.0 - 0.4 - 1.5 1.1 0.9 1.0
Digestive organs C15-26 39.7 38.4 38.7 36.1 37.3 37.9 42.4 34.1 40.0 38.8 33.8 36.8 35.8 37.7 37.6 36.3 36.1 33.5 40.2 38.8 47.0 38.1
  Oesophagus C15 1.3 1.0 1.4 1.8 1.1 0.8 1.0 0.9 0.4 0.3 1.2 0.6 1.2 1.4 0.7 0.7 0.6 0.5 1.0 1.2 1.2 1.1
  Stomach C16 3.7 4.2 4.2 4.9 3.3 3.5 4.2 3.3 5.5 4.8 4.2 3.3 3.1 3.7 4.0 3.8 4.1 3.9 2.4 4.2 4.8 3.8
  Small intestine C17 1.1 0.6 0.9 0.3 0.6 1.3 0.6 0.6 0.4 0.8 0.5 0.9 1.0 0.3 1.1 1.6 1.1 0.2 1.0 0.6 0.2 0.8
  Colon C18 14.3 14.5 13.6 12.0 12.5 12.1 15.8 12.3 13.7 10.5 8.8 13.6 13.2 14.1 11.6 14.2 12.3 10.0 16.8 11.9 21.4 13.4
  Rectum, rectosigmoid C19-20 6.6 5.9 6.2 5.5 7.7 6.8 8.0 5.5 9.9 6.9 7.3 5.6 5.5 7.0 6.7 4.3 5.0 5.9 4.2 6.6 7.2 6.5
  Anus C21 0.6 0.3 0.2 0.2 0.2 0.7 0.6 0.3 0.7 1.9 0.2 0.6 0.2 0.2 0.6 - 0.6 - 1.2 0.4 1.2 0.5
  Liver C22 2.4 2.5 1.9 1.9 2.5 2.0 2.4 1.4 2.0 3.4 2.8 2.8 1.6 2.1 2.2 1.6 2.7 1.8 1.7 2.3 3.2 2.3
  Gallbladder, bile ducts C23-24 1.5 1.7 1.5 3.1 2.2 2.7 2.0 2.3 2.1 1.1 2.4 2.1 1.0 2.1 1.3 2.7 2.2 2.2 2.7 2.7 0.2 1.9
  Pancreas C25 7.5 7.1 8.5 5.8 6.5 7.5 7.6 7.2 5.2 7.5 6.4 7.0 8.5 6.1 8.4 7.1 6.3 8.7 9.2 8.2 6.9 7.2
  Other digestive organs C26 0.6 0.5 0.3 0.6 0.6 0.5 0.2 0.2 0.2 1.6 0.1 0.3 0.6 0.8 0.8 0.4 1.2 0.4 0.1 0.7 0.6 0.6
Respiratory organs C30-39 17.7 13.9 10.9 12.5 10.8 11.9 16.1 12.1 12.3 10.4 9.0 9.8 8.9 8.7 11.8 11.0 12.0 12.9 16.4 16.1 18.7 13.3
  Nose, sinuses C30-31 0.3 0.2 0.2 0.3 0.2 0.2 0.3 0.6 0.3 - 0.2 0.1 0.3 0.4 0.3 0.1 0.4 - 1.0 0.4 - 0.3
  Larynx, epiglottis C32 0.4 0.5 - 0.1 0.4 0.1 0.4 - 0.4 0.4 0.1 0.3 - 0.2 0.1 - 0.2 - - - 0.7 0.3
  Lung, trachea C33-34 16.6 13.1 10.7 11.8 9.9 11.5 15.1 11.5 11.5 9.9 8.6 9.1 8.5 8.0 11.2 10.9 11.2 11.1 14.6 14.9 18.0 12.5
  Mediastinum, pleura C38 0.2 0.1 0.0 0.2 0.1 0.1 - 0.0 0.1 0.1 0.1 0.2 - 0.0 0.1 0.1 0.0 1.8 0.3 0.8 - 0.2
Bone C40-41 0.5 0.5 1.0 0.3 0.6 0.4 1.1 0.4 0.6 0.4 0.8 0.5 0.4 0.6 - - 0.4 0.3 1.7 0.8 - 0.5
Melanoma of the skin C43 18.1 14.2 11.6 9.9 13.9 11.0 15.0 12.6 10.0 7.4 9.7 10.3 10.4 10.4 9.2 9.8 7.5 9.3 6.8 5.9 22.4 13.3
Skin, non-melanoma C44 8.0 7.7 6.6 8.4 9.6 8.6 11.1 10.3 3.2 4.6 7.5 7.6 9.9 8.7 6.3 6.3 6.7 7.5 5.7 4.2 10.6 8.0
Mesothelioma C45 0.3 0.3 0.6 0.1 0.3 0.6 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.4 0.2 0.1 0.3 - 0.1 1.0 - 0.3
Autonomic nervous system C47 0.1 0.2 0.2 - - - 0.5 - - - - 0.1 0.2 0.2 - - - - - - - 0.1
Soft tissues C48-49 2.8 2.2 1.8 1.3 1.7 2.3 2.4 1.5 2.4 0.9 1.2 1.6 2.2 1.7 1.8 1.9 2.5 4.9 2.1 2.4 - 2.2
Breast C50 101 102 89.9 88.9 102 93.8 93.5 89.9 88.5 94.1 75.3 83.7 84.6 95.9 85.6 83.1 86.0 86.3 84.0 80.9 81.7 93.8
Female genital organs C51-58 28.3 27.6 31.1 29.6 31.2 29.8 34.3 28.4 32.6 25.8 30.6 31.1 26.7 34.0 37.2 29.3 30.0 27.3 31.0 25.6 36.7 29.7
  Cervix uteri C53 3.7 3.1 5.4 3.0 5.4 4.6 5.1 4.8 4.3 4.0 4.0 3.2 4.2 4.5 7.7 6.1 3.9 4.0 6.4 3.9 5.4 4.2
  Corpus uteri C54 12.9 13.3 14.3 14.3 14.9 14.2 13.3 11.7 15.6 10.4 15.3 16.1 11.6 17.2 15.0 14.2 13.5 11.1 13.6 11.3 11.2 13.7
  Uterus, other C55,C58 0.1 0.0 0.1 0.0 0.1 0.0 0.3 - - - - 0.0 0.1 0.1 0.1 - 0.1 0.1 0.2 0.1 1.0 0.1
  Ovary C56 8.0 8.9 8.5 8.3 8.7 6.9 12.6 9.7 10.1 8.6 7.8 8.1 8.9 8.5 11.8 6.8 9.0 9.0 7.6 8.2 14.1 8.7
  Other female genital C51-52,C57 3.6 2.4 2.9 3.8 2.1 4.0 3.0 2.2 2.7 2.8 3.6 3.6 1.9 3.7 2.5 2.3 3.5 2.9 3.1 2.1 5.0 3.0
Urinary organs C64-68 10.2 9.3 10.1 8.0 10.0 10.6 11.0 10.3 6.4 10.4 9.1 10.1 9.3 9.2 8.6 8.5 9.7 9.7 13.7 8.3 7.2 9.8
  Kidney C64 6.5 6.3 6.3 5.2 6.3 6.9 6.9 6.2 3.8 6.4 4.8 6.2 6.4 6.6 5.8 6.4 6.5 6.6 7.0 4.9 4.6 6.3
  Bladder and urinary tract3 C65-68 3.8 2.9 3.8 2.8 3.7 3.7 4.1 4.2 2.6 4.0 4.3 3.8 2.9 2.6 2.8 2.1 3.3 3.1 6.7 3.4 2.6 3.5
Eye C69 0.5 0.3 0.1 0.1 0.2 0.7 0.2 0.2 0.3 - 1.5 0.7 0.5 0.1 0.0 - 0.3 0.3 0.3 - 0.7 0.4
Brain, central nervous system C70-72,D32-33,D42-43 14.8 14.8 13.0 12.4 12.7 14.7 13.2 11.8 14.6 9.7 12.1 13.8 11.2 10.8 12.5 15.1 12.5 11.5 9.4 12.4 10.6 13.4
Thyroid gland C73 8.2 5.8 8.2 9.3 7.9 9.7 7.4 5.2 6.4 7.0 8.8 10.7 5.2 9.3 6.1 11.4 15.5 17.5 6.6 10.4 7.7 8.6
Other endocrine glands C74-75 0.7 0.1 0.1 0.1 0.8 0.4 0.6 1.0 - 0.5 1.1 0.3 0.2 0.4 0.8 - 0.6 0.7 - 0.2 - 0.5
Illdefined or unknown C76,C80 3.9 4.2 4.9 5.7 5.6 4.8 4.5 6.1 6.4 4.1 3.8 3.1 3.5 5.3 5.4 3.3 4.3 6.2 2.5 4.5 7.0 4.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 25.0 21.9 23.7 22.3 21.5 23.3 24.6 24.9 18.3 17.5 25.1 20.9 20.2 21.6 17.5 23.2 22.3 23.9 20.6 23.3 17.9 22.8
  Hodgkin lymphoma C81 2.2 2.7 2.8 1.2 3.2 1.8 1.2 2.2 2.1 0.4 3.5 3.1 1.6 2.1 1.5 2.2 2.0 0.3 2.4 0.9 1.5 2.2
  Non-Hodgkin lymphoma C82-86,C96,D76 11.1 8.2 9.5 10.1 9.8 9.9 9.2 8.1 6.4 10.2 11.0 9.3 8.9 8.2 8.5 8.7 9.2 10.7 8.4 11.0 8.8 9.7
  Malignant immunoproliferative diseases C88 0.3 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 - - 0.1 - 0.3 0.1 - 0.2 - - 0.0 - 0.2
  Myeloma and other plasma cell tumors C90 3.1 2.1 2.1 2.5 1.8 2.8 3.9 2.6 2.3 1.8 1.8 1.9 2.6 1.9 1.9 2.6 3.4 4.0 1.3 3.5 3.0 2.6
  Leukaemia C91-95 5.7 5.6 8.0 6.6 5.0 7.1 5.7 8.0 6.5 4.3 5.1 4.7 5.0 5.4 4.9 8.5 5.9 7.1 6.5 5.9 4.0 5.8
  Myelodysplastic syndromes D46 0.8 0.9 0.5 0.5 0.5 1.0 0.4 0.3 0.4 0.6 0.4 0.3 0.4 1.0 0.3 0.9 0.7 1.0 1.8 1.0 0.6 0.7
  Myeloproliferaitive neoplasms D45,D47 1.9 2.3 0.7 1.3 1.1 0.7 4.0 3.6 0.5 0.3 3.2 1.4 1.7 2.6 0.4 0.3 0.9 0.8 0.3 0.9 - 1.7
Not included above
  Carcinoma in situ of the breast D05 9.0 9.6 6.3 6.1 12.0 7.5 6.2 10.5 5.0 3.3 8.1 6.5 5.4 5.1 10.2 3.6 9.6 6.1 6.1 16.0 8.1 8.5
  Cervix uteri, non-invasive neoplasms 31.0 53.7 22.4 68.9 45.4 45.4 14.4 14.7 25.1 39.3 50.8 16.4 11.5 43.9 42.0 35.2 57.3 11.8 58.2 28.2 63.7 37.1
  Borderline tumour of the ovary D39 3.0 4.8 4.1 3.2 4.5 5.2 3.2 5.7 5.4 7.3 5.2 5.4 6.5 4.3 2.9 3.6 3.9 3.6 5.8 3.8 5.3 4.1
  Basal cell carcinoma of the skin 78.8 71.4 41.4 73.3 70.9 67.5 64.8 47.3 55.0 75.9 67.2 87.0 68.2 21.2 60.8 59.0 59.8 51.5 50.6 41.7 114 67.0
1 Adjusted for age to the "world standard population".
2 Health care districts: 25: Helsinki and Uusimaa, 3: Varsinais-Suomi, 4: Satakunta, 5: Kanta-Häme, 6: Pirkanmaa, 7: Päijät-Häme, 8: Kymenlaakso, 9: Etelä-Karjala, 10: Etelä-Savo, 11: Itä-Savo, 12: Pohjois-Karjala, 13: Pohjois-Savo, 14: Keski-Suomi, 15: Etelä-Pohjanmaa, 16: Vaasa, 17: Keski-Pohjanmaa, 18: Pohjois-Pohjanmaa, 19: Kainuu, 20: Länsi-Pohja, 21: Lappi, 22: Åland, (cf. map).
3 PUNLMP and ca in situ of the uroepithelium are included.